These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 26654598)

  • 1. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
    Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
    Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
    Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
    Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker.
    Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S
    J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.
    Kim KH; Seol HJ; Kim EH; Rheey J; Jin HJ; Lee Y; Joo KM; Lee J; Nam DH
    Neuro Oncol; 2013 Feb; 15(2):161-71. PubMed ID: 23258844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-β-catenin pathway.
    Yu P; Xu T; Ma W; Fang X; Bao Y; Xu C; Huang J; Sun Y; Li G
    J Exp Clin Cancer Res; 2024 Apr; 43(1):116. PubMed ID: 38637831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
    Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
    J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
    Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
    Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
    Wu B; Zhu J; Dai X; Ye L; Wang B; Cheng H; Wang W
    Int J Med Sci; 2021; 18(7):1609-1617. PubMed ID: 33746577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PL-hMSC and CH-hMSC derived soluble factors inhibit proliferation but improve hGBM cell migration by activating TGF-β and inhibiting Wnt signaling.
    Uthanaphun T; Manochantr S; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P
    Biosci Rep; 2024 May; 44(5):. PubMed ID: 38687607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation.
    Murray DW; Didier S; Chan A; Paulino V; Van Aelst L; Ruggieri R; Tran NL; Byrne AT; Symons M
    Br J Cancer; 2014 Mar; 110(5):1307-15. PubMed ID: 24518591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy Number Profiling of Brazilian Astrocytomas.
    Bidinotto LT; Torrieri R; Mackay A; Almeida GC; Viana-Pereira M; Cruvinel-Carloni A; Spina ML; Campanella NC; Pereira de Menezes W; Clara CA; Becker AP; Jones C; Reis RM
    G3 (Bethesda); 2016 Jul; 6(7):1867-78. PubMed ID: 27172220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway.
    Ding X; Deng G; Liu J; Liu B; Yuan F; Yang X; Chen Q
    Brain Res; 2019 Aug; 1717():117-126. PubMed ID: 30935831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2.
    Chung HJ; Choi YE; Kim ES; Han YH; Park MJ; Bae IH
    Oncotarget; 2015 Jul; 6(21):18429-44. PubMed ID: 26155940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition.
    Kahlert UD; Maciaczyk D; Doostkam S; Orr BA; Simons B; Bogiel T; Reithmeier T; Prinz M; Schubert J; Niedermann G; Brabletz T; Eberhart CG; Nikkhah G; Maciaczyk J
    Cancer Lett; 2012 Dec; 325(1):42-53. PubMed ID: 22652173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of β-catenin by IGFBP2 and its cytoplasmic actions in glioma.
    Verma BK; Kondaiah P
    J Neurooncol; 2020 Sep; 149(2):209-217. PubMed ID: 32803659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMOTL2‑knockdown promotes the proliferation, migration and invasion of glioma by regulating β‑catenin nuclear localization.
    Chen X; Lu Y; Guo G; Zhang Y; Sun Y; Guo L; Li R; Nan Y; Yang X; Dong J; Jin X; Huang Q
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.